Aims and Scope
Cancer Chemotherapy and Pharmacology is a peer-reviewed medical journal covering oncological pharmacotherapy. It was established in 1978 and is published by Springer Science+Business Media. The editors-in-chief are E.Chatelut (Paul Sabatier University) and E.A. Sausville (University of Maryland). It has been included in Index medicus (MEDLINE) since its first issue. According to the ISI 2016 Journal Citation Reports, the journal has an impact factor of 2.737, and its ranking was 98/254 (Pharmacology & Pharmacy) and 122/217 (Oncology). Less
Key Metrics
Journal Specifications
- PublisherSPRINGER
- LanguageEnglish
- FrequencyMonthly
- LanguageEnglish
- FrequencyMonthly
- Publication Start Year1978
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Months | % Papers published |
---|---|
0-3 | 18% |
4-6 | 61% |
7-9 | 19% |
>9 | 2% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Cancer Chemotherapy and Pharmacology been publishing? 
The Cancer Chemotherapy and Pharmacology has been publishing since 1978 till date.
How frequently is the Cancer Chemotherapy and Pharmacology published? 
Cancer Chemotherapy and Pharmacology is published Monthly.
Who is the publisher of Cancer Chemotherapy and Pharmacology? 
The publisher of Cancer Chemotherapy and Pharmacology is SPRINGER.
Where can I find a journal's aims and scope of Cancer Chemotherapy and Pharmacology? 
For the Cancer Chemotherapy and Pharmacology's Aims and Scope, please refer to the section above on the page.
How can I view the journal metrics of Cancer Chemotherapy and Pharmacology on editage? 
For the Cancer Chemotherapy and Pharmacology metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Cancer Chemotherapy and Pharmacology? 
The eISSN number is 1432-0843 and pISSN number is 0344-5704 for Cancer Chemotherapy and Pharmacology.
What is the focus of this journal? 
The journal covers a wide range of topics inlcuding Chemotherapy, Cancer, Lipid metabolism, Lung cancer, DNA repair, Methotrexate, Oral administration, Hepatocellular carcinoma, Bioavailability, Breast cancer, Toxicity, Irinotecan, Initial dose, Epidermal growth factor receptor, Crizotinib, Mitochondrial targeting, Overall survival, Renal function, Cisplatin, Diarrhea.
Why is it important to find the right journal for my research? 
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career? 
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only? 
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.